-
1 Comment
Canopy Growth Corporation is currently in a long term downtrend where the price is trading 20.4% below its 200 day moving average.
From a valuation standpoint, the stock is 97.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 29.5.
Canopy Growth Corporation's total revenue rose by 23.2% to $153M since the same quarter in the previous year.
Its net income has dropped by 647.6% to $-904M since the same quarter in the previous year.
Finally, its free cash flow grew by 62.8% to $-135M since the same quarter in the previous year.
Based on the above factors, Canopy Growth Corporation gets an overall score of 3/5.
None
Here's how to backtest a trading strategy or backtest a portfolio for 11L1.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
